Theriva Biologics, Inc. (TOVX) — DEF 14A Filings
All DEF 14A filings from Theriva Biologics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Theriva Biologics Seeks Shareholder Nod for 16.18M Warrant Share Issuance
— Nov 10, 2025 Risk: medium
Theriva Biologics, Inc. is holding a Special Meeting of Stockholders on December 15, 2025, to approve the issuance of up to 16,184,560 shares of common stock. T -
Theriva Biologics Seeks 80% Stock Plan Boost Ahead of Annual Meeting
— Jul 9, 2025 Risk: medium
Theriva Biologics, Inc. (TOVX) has filed a DEF 14A proxy statement for its 2025 Annual Meeting of Stockholders, scheduled for August 29, 2025, at 3:30 p.m. loca
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX